Latest Listicles

2018 has been an exciting year for the drug discovery field. This list details the top 10 most-read news stories we published from the field this year.

We have seen some amazing scientific breakthroughs in 2018.
This list highlights some of our favourites.

Similarly to other ‘omics’ technologies, the field of metabolomics has experienced substantial growth since the beginning of the century. That growth is thanks to technological advances and the wide range of potential applications that metabolomics has in other fields. In this list we highlight some of the most exciting technologies and applications in metabolomics.

In this list, we turn our attention to the most significant trends in the field of medicinal chemistry, and explore how they helped shape today’s pharma industry.

The retrospective identification of the drug targets that underlie an observed phenotypic response is termed target deconvolution. This list highlights five approaches that can be applied to target deconvolution.

Of 60 applications from across 17 countries, there were eight finalists who participated in the 'Startup Slam' — the Dragons' Den of Biopharma. Representatives of biotech companies presented to a jury of leading investors, pharma deal-makers and biotech business key opinion leaders at the BIO-Europe conference in Copenhagen, November 2018.

In vitro experiments are a mainstay of cancer research. However, it is crucial to select the appropriate cell line to yield meaningful insights from in vitro experiments. The cell line should reflect the type of cancer under scrutiny and should also be able to address the questions posed by the experiments.

Researchers spend their lives in pursuit of a scientific breakthrough. So, when that "eureka" moment finally arrives, of course it is tempting to give that groundbreaking discovery an absurd and memorable name. This list highlights four haunting Halloween-inspired scientific terms.

In this list, we discuss the process of developing an assay – a crucial test during various stages of drug discovery and development – highlighting the factors that impact the process.

Rapidly shifting research priorities, breakthrough innovations, and R&D investment are revealing new trends driving smart labs forward. In this list we explore 5 of these important trends.